Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus
about
Staphylococcus aureus biofilms: properties, regulation, and roles in human diseaseDevelopment of a vaccine against Staphylococcus aureusNeutrophil-Mediated Phagocytosis of Staphylococcus aureusBiomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratoriesInhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.Adhesive polypeptides of Staphylococcus aureus identified using a novel secretion library technique in Escherichia coli.Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Immunorelevant proteins for the diagnosis of bovine staphylococcal mastitis.Staphylococcus aureus seroproteomes discriminate ruminant isolates causing mild or severe mastitisEvaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.Genomic and surface proteomic analysis of the canine pathogen Staphylococcus pseudintermedius reveals proteins that mediate adherence to the extracellular matrix.Omics Approaches for the Study of Adaptive Immunity to Staphylococcus aureus and the Selection of Vaccine Candidates.Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection.Identification of commonly expressed exoproteins and proteolytic cleavage events by proteomic mining of clinically relevant UK isolates of Staphylococcus aureus.Multimer recognition and secretion by the non-classical secretion pathway in Bacillus subtilis.Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.The cell surface proteome of Staphylococcus aureus.Immune proteomics of Staphylococcus aureus.Current methodologies for proteomics of bacterial surface-exposed and cell envelope proteins.Differential epitope recognition in the immunodominant staphylococcal antigen A of Staphylococcus aureus by mouse versus human IgG antibodies.Lipoprotein immunoproteomics question the potential of Staphylococcus aureus TLR2 agonists as vaccine antigens.IVIG-mediated protection against necrotizing pneumonia caused by MRSA.Characterizing the surface-exposed proteome of Planococcus halocryophilus during cryophilic growth.Excretion of cytoplasmic proteins (ECP) in Staphylococcus aureus.Elongation factor Tu is a multifunctional and processed moonlighting protein.Montanide ISA 71 VG is Advantageous to Freund's Adjuvant in Immunization Against S. aureus Infection of Mice.Immunoproteomic characterisation of Mycoplasma mycoides subspecies capri by mass spectrometry analysis of two-dimensional electrophoresis spots and western blot.CD4 T cell antigens from Staphylococcus aureus Newman strain identified following immunization with heat-killed bacteria.Proteomics of Staphylococcus aureus biofilm matrix in a rat model of orthopedic implant-associated infection.Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteins.Hierarchy of human IgG recognition within the Staphylococcus aureus immunome
P2860
Q27006715-04E56E6C-6190-4098-9C2B-5E813FFE0CB5Q27015365-077AB6E3-3017-4677-9B31-B225ABABF2D6Q27025128-8DC49365-CA75-471A-A24D-ACC273233F8CQ27028051-A56A74C2-D00A-460E-83CA-3846ABF314B3Q33719201-4BC2EF17-C4A5-4B21-A7AB-05D40A99F10CQ33913148-9B07F1F2-11F7-490B-85DD-669988763A61Q34113328-13B74B68-D717-49F4-A1CE-AB60A88E116DQ34578080-EAACF1BD-95D4-4A01-BE84-1C7423D094D0Q34639298-287828C6-C243-4404-840C-23D61933683EQ34712265-98B1D563-DFFE-40F1-BE5A-23CEFFEC7C14Q35139269-A00D28C7-6CE3-463D-97BE-89A9FAA0299AQ37566435-036F980D-66E6-4AB4-8112-8FEBDEEEBF79Q37643833-E359BD9E-C214-424B-9E9F-2A2059F04488Q37658080-87752B05-7A48-478D-A6ED-FFF05EE812B4Q37690436-2622EB40-ADE2-466C-B4AB-3714ED8E747DQ37878489-391A1FFC-64ED-48E2-A1F5-C46D81AAE796Q37883257-54AE68C8-B5DD-4A57-9F20-80E29458250CQ37895214-5F4C016D-DF05-47E8-A466-A97EA6C2E1D8Q37897206-3A54CF40-2AEB-4251-9F4F-AA57FA7F1B2CQ38642002-B77F36A8-B58C-408A-88B0-9148C8255AF9Q40528006-6F1358D4-32FC-4A3B-9690-E68C3479B2BEQ40531502-3FF5207B-FB20-4A33-AF26-997C63A3BB81Q41127016-3CACC093-7BE6-4BBB-8AE5-25B4BB4C8102Q41203338-930A8E76-C353-45DD-8E4E-02594325C983Q41326084-CFF36909-7B2B-4221-8155-9BA972F4E2D4Q41479231-93111E0B-3C72-41F6-8BAC-AE922FFF1069Q41605663-2DE3086E-22AC-42B4-A5B8-132E96F887F4Q42109044-98522D54-9DCE-4315-ABEB-D5CF24EEED1DQ47103885-4A36497F-1676-4FED-97F3-FDB1AF1CAECCQ49830644-A6E757AF-CA22-42BF-80C0-3FF1AFFBC008Q58763401-6EAB4641-23B0-4169-A939-A0741EB90158
P2860
Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Proteomics-based identificatio ...... against Staphylococcus aureus
@ast
Proteomics-based identificatio ...... against Staphylococcus aureus
@en
type
label
Proteomics-based identificatio ...... against Staphylococcus aureus
@ast
Proteomics-based identificatio ...... against Staphylococcus aureus
@en
prefLabel
Proteomics-based identificatio ...... against Staphylococcus aureus
@ast
Proteomics-based identificatio ...... against Staphylococcus aureus
@en
P2093
P2860
P356
P1476
Proteomics-based identificatio ...... against Staphylococcus aureus
@en
P2093
Bettina Tosetti
Eva Glowalla
Martin Krönke
P2860
P304
P356
10.1128/IAI.00617-08
P407
P577
2009-04-13T00:00:00Z